PPL
67
-2
WM
80
-4
NKE
39
2
FFIV
64
2
COP
47
2
CAT
69
3
CTSH
49
-2
PEG
55
2
ADP
68
2
BLK
69
11
FRT
53
3
KIM
51
4
DRI
63
3
TSN
38
-2
KSS
47
-4
WDC
49
-4
DVA
73
2
EL
55
-3
GOOG
75
2
AIG
66
4
PPL
67
-2
WM
80
-4
NKE
39
2
FFIV
64
2
COP
47
2
CAT
69
3
CTSH
49
-2
PEG
55
2
ADP
68
2
BLK
69
11
FRT
53
3
KIM
51
4
DRI
63
3
TSN
38
-2
KSS
47
-4
WDC
49
-4
DVA
73
2
EL
55
-3
GOOG
75
2
AIG
66
4
Financhill
Back

Royalty Pharma PLC Quote, Financials, Valuation and Earnings

Sell
31

RPRX
Royalty Pharma PLC

Last Price:
27.26
Seasonality Move:
-2.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Royalty Pharma PLC Price Quote

$27.26
-0.01 (-2.22%)
(Updated: May 18, 2024 at 5:52 AM ET)

Royalty Pharma PLC Key Stats

Sell
31
Royalty Pharma PLC (RPRX) is a Sell
Day range:
$27.24 - $27.83
52-week range:
$25.92 - $34.65
Dividend yield:
3.01%
P/E ratio:
10.78
P/S ratio:
7.32
P/B ratio:
1.89%
Volume:
1.9M
Avg. volume:
2.8M
1-year change:
-17.24%
Market cap:
$12.3B
Revenue:
$2.4B
EPS:
$1.77

How Much Does Royalty Pharma PLC Make?

Is Royalty Pharma PLC Growing As A Company?

  • What Is Royalty Pharma PLC's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.17%
  • What Is Royalty Pharma PLC's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.99%

Royalty Pharma PLC Stock Price Performance

What Is Royalty Pharma PLC 52-Week High & Low?

Royalty Pharma PLC Price To Free Cash Flow

Is It Risky To Buy Royalty Pharma PLC?

Is Royalty Pharma PLC Cash Flow Positive?

  • What Is RPRX Cash Flow From Operations?
    Cash flow from operations (TTM) is $2.6B
  • What Is Royalty Pharma PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$2.2B
  • What Is Royalty Pharma PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.6B

Royalty Pharma PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    RPRX return on invested capital is 4.88%
  • What Is Royalty Pharma PLC Return On Assets?
    ROA measures how assets are converting to revenues and is 4.84%
  • What Is RPRX Return On Equity?
    ROE is a measure of profitability and is 8.12%

Royalty Pharma PLC Earnings Date & Stock Price

Royalty Pharma PLC Competitors

  • Who Are Royalty Pharma PLC's Competitors?
    Below is a list of companies who compete with Royalty Pharma PLC or are related in some way:
    • Amgen Inc (AMGN)
    • Arrowhead Pharmaceuticals Inc (ARWR)
    • Ironwood Pharmaceuticals Inc (IRWD)
    • Maravai LifeSciences Holdings Inc (MRVI)
    • Viatris Inc (VTRS)

Royalty Pharma PLC Dividend Yield

Royalty Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: -98.68% -0.35%
Revenue: -16.96% -19.94%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 45.75
Upside from Last Price: 67.77%

Major Shareholders

  • How many RPRX shares are owned by institutional investors?
    487.5M RPRX shares are owned by institutional investors
  • How many RPRX shares are owned by insiders?
    824.6K RPRX shares are owned by insiders